Jesse Costa/WBUR
After Opioid Overdose, Only 30 Percent Get Medicine To Treat Addiction
Patients revived from an opioid overdose who get methadone or Suboxone treatment for addiction afterward are much more likely to be alive a year later, says a study published in the Annals of Internal Medicine.
If You’ve Got Hep C, Spitting Can Be A Felony
About a dozen states have added hepatitis C to the list of medical conditions for which people can face criminal prosecution if they engage in certain activities like sex without disclosure, needle-sharing or organ donation.
Unwieldy Health Costs Often Stand Between Teachers And Fatter Paychecks
Cash-strapped school boards, cities and legislatures scrounge to cover pay raises and pricey benefits and turn to teachers to fork over more of their shrinking take-home pay.
How America Got Hooked On A Deadly Drug
An inside look at how Purdue Pharma pushed OxyContin despite risks of addiction and fatalities.
As Medicaid Costs Soar, States Try A New Approach
New programs, known as ACOs, reward hospitals and physician groups that hold down costs by keeping enrollees healthy. The health care providers are asked to address social issues — such as homelessness, lack of transportation and poor nutrition — that can cause and exacerbate health problems.
Postcard From D.C. Courthouse: Medicaid Work Requirements And Manafort
Puerto Rico’s Water System Stutters Back To Normal
In New Hampshire, Even Mothers In Treatment For Opioids Struggle To Keep Children
Must-Reads Of The Week From Brianna Labuskes
Medicare Takes Aim At Boomerang Hospitalizations Of Nursing Home Patients
Podcast: KHN’s ‘What The Health?’ California Here We Come
5 Things To Know About Medicaid Work Requirements
Most Texans Want State To Expand Medicaid And Help Poor Get Health Care
That ‘Living Will’ You Signed? At The ER, It Could Be Open To Interpretation.
Pre$cription For Power: The Patient Advocacy Database
Patient advocacy groups campaign to raise awareness of diseases, to fund research and to promote policies favorable to their causes on Capitol Hill and at the Food and Drug Administration. But do they represent patients or Big Pharma? Kaiser Health News has compiled and analyzed disclosures to shed light on the flow of money between the pharmaceutical industry and patient advocacy groups.
Stay informed by signing up for the KHN Morning Briefing and other emails:
